Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2356-2363

  Yuan, Jiangzi ^a,b   Guo, Qunying ^a,c   Qureshi, Abdul Rashid ^a   Anderstam, Björn ^a   Eriksson, Monica ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Stenvinkel, Peter ^a   Lindholm, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Inflammation; Mortality; SFlt 1

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; SOLUBLE VASCULOTROPIN RECEPTOR 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL RATE;

CHRONIC KIDNEY DISEASE; INFLAMMATION; MORTALITY; SFLT-1;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84884521782     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft256     Document Type: Article

References (37)

1. Tonelli M, Wiebe N, Culleton B et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006; 17: 2034-2047
2. Baber U, de Lemos JA, Khera A et al. Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort. Kidney Int 2008; 73: 615-621
3. Hoeben A, Landuyt B, Highley MS et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-580
4. Olsson AK, Dimberg A, Kreuger J et al. VEGF receptor signalling -in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371
5. Guo Q, Carrero JJ, Yu X et al. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients. Nephrol Dial Transplant 2009; 24: 3468-3473
6. Mallamaci F, Benedetto FA, Tripepi G et al. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients. J Hypertens 2008; 26: 1875-1882
7. Di Marco GS, Reuter S, Hillebrand U et al. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J Am Soc Nephrol 2009; 20: 2235-2245
8. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
9. Johnson R, McNutt P, MacMahon S et al. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem 1997; 43: 2183-2184
10. Section I. Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 2002; 17(Suppl. 7): 7-15
11. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773-782
12. Honda H, Qureshi A, Heimbürger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148
13. Ho QT, Kuo CJ. Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 2007; 39: 1349-1357
14. Siervo M, Ruggiero D, Sorice R et al. Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition 2012; 28: 262-266
15. Sung SH, Ziyadeh FN, Wang A et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006; 17: 3093-3104
16. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611
17. Futrakul N, Butthep P, Laohareungpanya N et al. A defective angiogenesis in chronic kidney disease. Ren Fail 2008; 30: 215-217
18. Harper SJ, Downs L, Tomson CR et al. Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia. Nephron 2002; 90: 341-343
19. Watorek E, Paprocka M, Dus D et al. Endostatin and vascular endothelial growth factor: potential regulators of endothelial progenitor cell number in chronic kidney disease. Pol Arch Med Wewn 2011; 121: 296-301
20. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252
21. Miyazawa-Hoshimoto S, Takahashi K, Bujo H et al. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003; 46: 1483-1488
22. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949
23. Utsal L, Tillmann V, Zilmer M et al. Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-gamma levels in 10-to 11-year-old boys with increased BMI. Horm Res Paediatr 2012; 78: 31-39
24. Stam F, van Guldener C, Becker A et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 2006; 17: 537-545
25. Yoshikawa N, Noda K, Shinoda H et al. Serum Vascular Adhesion Protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes. J Diabetes Complications 2013; 27: 162-166
26. Ucciferri C, Falasca K, Mancino P et al. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. Eur Rev Med Pharmacol Sci 2012; 16: 491-498
27. Bi XY, He X, Zhao M et al. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury. J Cardiovasc Pharmacol 2013; 29: 391-400
28. Tong M, Carrero JJ, Qureshi AR et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007; 2: 889-897
29. Krishnamurthy VM, Wei G, Baird BC et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 2012; 81: 300-306
30. Kalamatianos T, Stavrinou LC, Koutsarnakis C et al. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development. J Neurosurg 2013; 118: 353-357
31. Cindrova-Davies T, Sanders DA, Burton GJ et al. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res 2011; 89: 671-679
32. Pecoits-Filho R, Goncalves S, Barberato SH et al. Impact of residual renal function on volume status in chronic renal failure. Blood Purif 2004; 22: 285-292
33. Kwon O, Ahn K, Zhang B et al. Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI. Ren Fail 2010; 32: 699-708
34. Shapiro NI, Yano K, Okada H et al. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 2008; 29: 452-457
35. Hooper CE, Elvers KT, Welsh GI et al. VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes. Lung Cancer 2012; 77: 443-449
36. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) 1999; 77: 527-543
37. Wada T, Jesmin S, Gando S et al. Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome. Crit Care 2012; 16: R171